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Accepted 21 May 2010AbstractObjective: To report five cases of major congenital malformations associated with common aneuploidies detected by rapid aneuploidy diagnosis.
Case Reports: The fetus in the first case presented cebocephaly, semilobar holoprosencephaly, and tetralogy of Fallot on ultrasound at 25
gestational weeks. Cordocentesis using multiplex ligation-dependent probe amplification to detect aneuploidies of chromosomes X, Y, 13, 18,
and 21 in uncultured cord blood revealed three copies of all targets on chromosome 13 consistent with the diagnosis of trisomy 13. The fetus in
the second case presented bilateral choroid plexus cysts, congenital diaphragmatic hernia, and club foot on ultrasound at 18 gestational weeks.
Amniocentesis using array-based comparative genomic hybridization (aCGH) in uncultured amniocytes revealed a gain in the DNA dosage of
chromosome 18 consistent with the diagnosis of trisomy 18. The fetus in the third case presented aortic stenosis and nuchal edema on ultrasound
at 22 gestational weeks. Amniocentesis using aCGH in uncultured amniocytes revealed a result of monosomy X and Turner syndrome. The fetus
in the fourth case presented nuchal cystic hygroma and ventriculomegaly on ultrasound at 17 gestational weeks. Amniocentesis using aCGH in
uncultured amniocytes revealed a gain in the DNA dosage of chromosome 21 consistent with the diagnosis of trisomy 21. The fetus in the fifth
case presented holoprosencephaly, omphalocele, and hydronephrosis on ultrasound at 17 gestational weeks. Amniocentesis using aCGH in
uncultured amniocytes revealed a gain in the DNA dosage of chromosome 13 consistent with the diagnosis of trisomy 13.
Conclusions: Prenatal diagnosis of major congenital malformations should alert one to the possibility of chromosomal abnormalities. Multiplex
ligation-dependent probe amplification and aCGH have the advantage of rapid aneuploidy diagnosis of common aneuploidies in cases with
major congenital malformations.
Copyright  2011, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Rapid aneuploidy diagnosis (RAD) refers to the applica-
tions of molecular cytogenetic techniques such as interphase
fluorescence in situ hybridization, quantitative fluorescent
polymerase chain reaction, multiplex ligation-dependent probe
amplification (MLPA), and array-based comparative genomic
hybridization (aCGH) for rapid prenatal diagnosis of common
aneuploidies [1]. Common aneuploidies, such as trisomies 13,
18 and 21, Turner syndrome (45,X), Klinefelter syndrome
(47,XXY), triple X (47,XXX), 47,XYY, and triploidy account
for more than 80% of significant chromosomal abnormalities
diagnosed in the prenatal period [1]. Other chromosomal
aberrations, such as balanced and unbalanced translocations,
deletions, duplications, inversions, isochromosomes, and
marker chromosomes account for only a small part of prena-
tally detected chromosomal abnormalities. Here, we presentFig. 1. Prenatal ultrasound of Case 1 at 25 gestational weeks shows cebocephaly
dimensional ultrasound, and (C) semilobar holoprosencephaly.our experience of RAD by MLPA and aCGH in pregnancy
with major congenital malformations.
Case reportsCase 1A 26-year-old primigravid woman underwent cordocentesis
at 25 gestational weeks because of congenital malformation of
the fetal brain. Prenatal ultrasound at 25 gestational weeks
revealed cebocephaly with a single nostril, semilobar hol-
oprosencephaly (HPE), and tetralogy of Fallot (Fig. 1). About
2 mL blood was aspired, of which 1 mL of blood was
applied for MLPA using SALSA MLPA P095 aneuploidy kit
(MRC-Holland bv, Amsterdam, The Netherlands) to detect
aneuploidies of chromosomes X, Y, 13, 18, and 21, and 1 mL
of blood was applied for conventional cytogenetic analysis.with a single nostril (arrow) on (A) three-dimensional ultrasound, (B) two-
Fig. 2. Multiplex ligation-dependent probe amplification in Case 1 shows a male fetus with three copies of all targets on chromosome 13 consistent with the
diagnosis of trisomy 13. The wild type in a normal male control has two copies of all targets on chromosome 13. Arrows indicate chromosome 13 targets.
WT¼wild type; ANEU¼ aneuploidy test; ANEU-024¼Case 1; ANEU-WT¼wild type (control).
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three copies of all targets on chromosome 13, two copies of all
targets for chromosomes 18 and 21, and one copy of all targets
for the X and Y chromosomes within the P095 kit [mlpa
X,Y (P095) 1, 13 (P095) 3, 18,21 (P095) 2] (Fig. 2),
consistent with the diagnosis of trisomy 13. Conventional
cytogenetic analysis revealed a karyotype of 47,XY,þ13. The
parents decided to terminate the pregnancy.Case 2A 39-year-old, gravida 3, para 2, woman underwent
amniocentesis at 18 gestational weeks because of advanced
maternal age. Prenatal ultrasound before amniocentesis
revealed bilateral choroid plexus cysts, congenital diaphrag-
matic hernia (CDH), and club foot. The fetal biometry was
equivalent to 17 weeks. About 32 mL amniotic fluid was
aspired, of which 15 mL of amniotic fluid was applied
for aCGH using uncultured amniocytes, and 15 mL was
applied for conventional cytogenetic analysis using cultured
amniocytes. Within 3 days, bacterial artificial chromosome
(BAC)-based aCGH showed the result of trisomy 18 [arr cgh
18p11.32q23 (RP11-1150C18/ RP11-87C15) 3] (Fig. 3).
Eleven days after amniocentesis, conventional cytogenetic
analysis revealed a karyotype of 47,XX,þ18. The parents
decided to continue the pregnancy. Prenatal ultrasound at 34
gestational weeks revealed polyhydramnios and a malformed
fetus with intrauterine growth restriction, single umbilical
artery, a flat facial profile, micrognathia, CDH, club feet,
clenched hands, and a ventricular septal defect (Fig. 4).Fig. 3. Bacterial artificial chromosomeebased array comparative genomic hybrid
diagnosis of trisomy 18.Case 3A 29-year-old, gravida 4, para 1, woman underwent
amniocentesis at 23 gestational weeks because of fetal
congenital anomalies. Prenatal ultrasound at 22 gestational
weeks revealed aortic stenosis (AS) with a thickened aortic
valve and a turbulent jet in the ascending aorta, and nuchal
edema with a thick nuchal fold of 0.95 cm (Fig. 5). About
38 mL amniotic fluid was aspired, of which 20 mL of amniotic
fluid was applied for aCGH using uncultured amniocytes, and
15 mL was applied for conventional cytogenetic analysis
using cultured amniocytes. Within 3 days, BAC-based
aCGH showed the result of monosomy X [arr cgh 1-22 (2,853
BAC) 2, X (158 BAC)  1, Y (27 BAC) 0] (Fig. 6). Ten
days after amniocentesis, conventional cytogenetic analysis
revealed a karyotype of 45,X. The parents decided to terminate
the pregnancy. The parental karyotypes were normal.Case 4A 37-year-old, gravida 5, para 3, woman underwent amnio-
centesis at 18 gestational weeks because of advanced maternal
age and fetal congenital anomalies. Prenatal ultrasound at 17
gestational weeks revealed ventriculomegaly and nuchal cystic
hygroma (Fig. 7). About 36 mL amniotic fluid was aspired, of
which 20 mL of amniotic fluid was applied for aCGH using
uncultured amniocytes, and 15mLwas applied for conventional
cytogenetic analysis using cultured amniocytes. Within 3 days,
BAC-based aCGH showed the result of trisomy 21 [arr cgh
21p11.2q22.3 (RP11-430M17/RP11-1000I21) 3] (Fig. 8).ization in Case 2 shows a duplication of chromosome 18 consistent with the
Fig. 4. Prenatal ultrasound of Case 2 at 34 gestational weeks shows (A) a clenched hand, (B) a club foot, (C) congenital diaphragmatic hernia with a stomach (S) in
the chest and a heart (H) with a ventricular septal defect (arrow), and (D) a flat face with micrognathia.
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revealed a karyotype of 47,XY,þ21. The parents decided to
terminate the pregnancy.Case 5A 37-year-old, gravida 2, para 1, woman underwent amnio-
centesis at 17 gestational weeks because of advanced maternal
age and fetal congenital anomalies. Prenatal ultrasound at 17
gestational weeks revealed alobar HPE, mild hydronephrosis,
and a small omphalocele containing the bowel (Fig. 9). About
38 mL amniotic fluid was aspired, of which 20 mL of amniotic
fluid was applied for aCGH using uncultured amniocytes, and
17 mL was applied for conventional cytogenetic analysis usingcultured amniocytes. Within 3 days, BAC-based aCGH showed
the result of trisomy 13 [arr cgh 13q11q34 (RP11-
631L24/ RP11-450H16) 3] (Fig. 11). Ten days after
amniocentesis, conventional cytogenetic analysis revealed
a karyotype of 47,XY,þ13. The pregnancy was subsequently
terminated, and a 146-g fetus was delivered with premaxillary
agenesis, omphalocele, and polydactyly of both feet (Fig. 10).
Discussion
MLPA, first described by Schouten et al [2], is a molecular
method to detect gene dosage abnormalities in a wide range of
conditions by relative quantification of up to 45 DNA target
sequences in one polymerase chain reaction with the input of
Fig. 5. Prenatal ultrasound of Case 3 at 22 gestational weeks shows (A) nuchal edema with a thick nuchal fold of 0.95 cm and (B) aortic stenosis with a thickened
aortic valve and a turbulent jet (yellow color) in the ascending aorta. AO¼ ascending aorta; LV¼ left ventricle; RV¼ right ventricle.
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cells or cell cultures. It can be automated and can obtain the
result as quickly as 30 hours [3]. In MLPA, it is the probes
added to the samples that are amplified and quantified [4]. TheFig. 6. Bacterial artificial chromosomeebased array comparative genomic hybridi
syndrome.MLPA kit for RAD is commercially available. For the SALSA
MLPA P095 aneuploidy kit, eight target sequences are chosen
for each of the chromosomes 13, 18, 21, and X, and four target
sequences are chosen for the chromosome Y. MLPA canzation in Case 3 shows monosomy X consistent with the diagnosis of Turner
Fig. 7. Prenatal ultrasound of Case 4 at 17 gestational weeks shows (A) bilateral ventriculomegaly and (B) nuchal cystic hygroma.
Fig. 8. Bacterial artificial chromosomeebased array comparative genomic hybridization in Case 4 shows a duplication of chromosome 21 consistent with the
diagnosis of trisomy 21.
Fig. 9. Prenatal ultrasound of Case 5 at 17 gestational weeks shows (A) alobar holoprosencephaly and (B) a small omphalocele.
Fig. 10. (A) A trisomy 13 fetus with premaxillary agenesis, omphalocele, and
polydactyly of feet. (B) Polydactyly of both feet.
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accuracy of MLPA for detecting common aneuploidies of
chromosomes X, Y, 13, 18, and 21 is comparable with that of
karyotyping [3,5e12]. Compared with conventional kar-
yotyping, MLPA has the advantages of sparing the waiting
time and reducing the cost, but the disadvantages of an
inability to detect structural chromosomal abnormalities,
maternal cell contamination, and triploidy [1,13]. It has been
reported that MLPA is not expected to detect chromosome
mosaicism [6,8]. However, in a prospective study of 4,000
amniotic fluid samples, Van Opstal et al [3] was able to detect
some mosaic cases, structural chromosome aberrations, and
male fetuses with triploidy by calculating the cutoff values for
all the probes in the P095 MLPA kit and comparing the
relative probe signals with the normal cutoff values.BAC-based and oligonucleotide-based aCGH are compre-
hensive and high-resolution genome-wide screening methods
to obtain DNA copy number information in a single rapid
measurement without the requirement of living cells or cell
cultures [1,13]. aCGH has the ability to detect DNA dosage
imbalance including deletions and duplications and the
inability to detect very low-level mosaicism, balanced trans-
locations, inversions, and polyploidy. aCGH has proven to be
invaluable for RAD of unbalanced chromosomal abnormalities
in uncultured amniocytes [14]. Recent studies have suggested
that aCGH can detect as little as 20% (and possibly 10%)
mosaicism for the peripheral blood [15,16].
Our Case 1 was associated with HPE and cebocephaly. In
this case, the facial dysmorphism of a single nostril was
evident by two- and three-dimensional prenatal ultrasound.
Chen et al [17] previously described the dysmorphism of
a prominent nose and a large common nasal cavity in
a trisomy 13 fetus with cebocephaly. Cytogenetic abnormali-
ties have been reported in 24e45% of live births with HPE
[18e20]. In a meta-analysis of chromosomal abnormalities
associated with HPE, Blaas et al [21] suggested that the
frequency was 34.7% (92/265) or more. Reported chromo-
somal abnormalities associated with HPE include trisomy 13,
trisomy 18, triploidy, del(2p), dup(3p), del(7q), del(13q), del
(18p), del(21q), and interstitial deletion of 14q13 [22,23].
Several new submicroscopic rearrangements have been iden-
tified by aCGH in HPE cases such as interstitial deletions of
1p, 6q, 10p, 16p, 18q, 20p, 21q, and Xp, and subtelomeric
deletions in 19pter and 6qter [24]. HPE can be a first-trimester
sonographic feature of fetuses in trisomy 13 pregnancies [25].
HPE has been found in 26.5% (48/181) of trisomy 13 fetuses
in the first trimester [26]. In a meta-analysis of fetal trisomy 13
diagnosed in the second and third trimesters, Chen [25] found
the mean frequency of HPE in trisomy 13 was 27% (64/237).
Our Case 2 was associated with CDH. Snijders et al [27]
found that CDH was diagnosed in 10% of fetuses with trisomy
18. CDH can be associated with chromosomal abnormalities
[28]. Trisomies 13, 18, and 21, and 45,X are the most common
aneuploidies associated with CDH [29e31]. Frequently repor-
ted structural chromosomal abnormalities associated with CDH
include tetrasomy 12p (Pallister-Killian syndrome), del(15)
(q26.1eq26.2), del(8)(p23.1), cytogenetic rearrangements of
8q23, del(4)(p16), þder(22) t(11;22)(q23;q11), and del(1)
(q41eq42.12) [30e33]. Other reported chromosomal rear-
rangements associated with CDH include duplication of
1q25eq31.2, deletion or duplication of 2q37, deletion of 3q22,
deletion or duplication of 4q31, deletion of 5p15, deletion of
6p25, deletion of 6q25.3-qter, duplication of 8p21ep23.1,
deletion of 8q22eq23, deletion of 9p24-pter, deletion of 11p13,
duplication of 11q23.3-qter, duplication of 12p and duplication
of 14q32 [31]. CDH has been seen in patients with tetrasomy 21,
trisomy 22, and trisomy 9 [30,34,35].
Our Case 3 was associated with AS with nuchal edema.
Snijders et al [27] found that nuchal edema was diagnosed in
6% of fetuses with Turner syndrome. About one-third of
fetuses with nuchal edema have chromosomal abnormalities,
mainly trisomies 21, 18, and 13 [28]. Song et al [36] found
Fig. 11. Bacterial artificial chromosome-based array comparative genomic hybridization in Case 5 shows a duplication of chromosome 13 consistent with the
diagnosis of trisomy 13.
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with AS. In a study of 179 patients with Turner syndrome,
Gøtzsche et al [37] found that 46 (25.7%) patients had
cardiovascular malformations, 33 (18.4%) patients had aortic
valve abnormalities, and 18 (10.1%) patients had aortic
coarctation. Prandstraller et al [38] found that patients with
Turner syndrome had a higher prevalence (29/136 ¼ 21.3%) of
congenital heart defects than the general population (21.3% vs.
0.8%, 27 times more frequent). Prandstraller et al [38] found
that among the congenital heart defects, partial anomalous
pulmonary venous return appeared to be the most prevalent
anomaly (4/136 ¼ 2.9%) (2.9% vs. 0.009%, 322 times more
frequent) followed by aortic valve disease (AS and/or
incompetence) (7/136 ¼ 5.1%) (5.1% vs. 0.035%, 146 times
more frequent) and aortic coarctation (6/136 ¼ 4.4%) (4.4%
vs. 0.043%, 102 times more frequent).
Our Case 4 was associated with ventriculomegaly and
nuchal cystic hygroma. Snijders et al [27] found that ven-
triculomegaly was diagnosed in 16% of fetuses with trisomy
21. Ventriculomegaly can be associated with chromosomal
abnormalities [23]. Snijders et al [27] reported chromosomal
abnormalities in 13% of fetuses with prenatally detected
ventriculomegaly, and trisomies 18, 13, and 21 and triploidy
are the most common aneuploidies associated with ven-
triculomegaly. Snijders et al [27] found that cystic hygroma
was diagnosed in 1% of fetuses with trisomy 21. Cystic
hygroma can be associated with chromosomal abnormalities
[28]. Snijders et al [27] reported chromosomal abnormalities
in 68% of fetuses with prenatally detected cystic hygroma, andTurner syndrome, trisomy 21, and trisomy 18 are the most
common aneuploidies associated with cystic hygroma.
Our Case 5 was associated with HPE, omphalocele, mild
hydronephrosis, and polydactyly. Snijders et al [27] found that
omphalocele was diagnosed in 17% of fetuses with trisomy 13.
Snijders et al [27] reported chromosomal abnormalities in 35%
of fetuses with prenatally detected omphalocele, and trisomies
18 and 13 are the most common aneuploidies. Snijders et al
[27] found that mild hydronephrosis was diagnosed in 37% of
fetuses with trisomy 13. The reported frequencies of poly-
dactyly in fetuses with trisomy 13 range from 7.1% to 21.2%
[28].
In conclusion, prenatal diagnosis of major congenital
malformations should alert one to the possibility of chromo-
somal abnormalities. MLPA and aCGH have the advantage of
RAD of common aneuploidies in cases with major congenital
malformations.
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